Research & Development

A. R&D / Finished Formulations

The Research and Development operations for both generic and innovative formulations are supported by two advanced, autonomous laboratories, housed in a 1200 m2 building in Pallini/Athens. These premises feature a GLP/GMP compliant environment, where lab-scale and pilot-scale development are conducted. Scaling-up is executed in collaboration with the Industrial Units following quality and process control strategies.

With the application of innovative techniques and advances technologies, Pharmathen aims to provide Life Cycle Management solutions to brand companies as well as to develop and establish new technology platforms and provide optimized pharmaceutical products to patients.

Our extensive R&D operations have resulted in Intellectual Property that is protected by many patents. These were granted by the European Patent Office (EPO), the United States Patent and Trademark Office, USPTO and patent applications (PCT applications). Currently, Pharmathen holds 93 patents in its portfolio.

In order to explore advanced and pioneering pharmaceutical technologies as well as their application on an industrial scale, Pharmathen’s R&D Department is also actively involved in a number of research projects, in collaboration with renowned Universities and Research Centers across the E.U.

B. R&D / Active Pharmaceutical Ingredients

The APIs operations are supported by the API Research and Development Centre located in Thessaloniki, Greece.

Our lab features the most hi-tech instrumentation and equipment. This results in the development of high-quality products through innovating cost-effective processes, compliance with the standards of International Guidelines and Pharmacopoeias, as well as on-time delivery.

Our center's management system, structure and established partnerships with contract manufacturers offers:

• Innovative , non-infringing, cost effective processes
• Analytical method development and validation
• Quality control of all stages of process (from raw material to final API)
• Genotoxic evaluation and control of impurities
• Control of cost in all stages of process (raw materials, intermediates, manufacturing cost)
• Pilot and commercial quantities of APIs